Sequoia Fund Reopens to New Investors After Plunge in Assets

  • Valeant stock dive hurt results, reputation at storied fund
  • Sequoia will remain closed to those buying via third parties

Sequoia Fund, the Valeant Pharmaceuticals International Inc. holder whose assets fell as slumping performance led to outflows, is reopening to new investors.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.